Health and FitnessHealth and Fitness
Mon, January 9, 2012

3SBio Inc. to Present at the UBS Greater China Conference 2012


Published on 2012-01-09 05:16:55 - Market Wire
  Print publication without navigation


3SBio Inc. to Present at the UBS Greater China Conference 2012 -- SHENYANG, China, Jan. 9, 2012 /PRNewswire-Asia-FirstCall/ --

3SBio Inc. to Present at the UBS Greater China Conference 2012

[ ]

SHENYANG, China,Jan. 9, 2012 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: [ SSRX ]) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced Mr. Bo Tan, 3SBio's chief financial officer will attend the UBS Greater China Conference 2012 in Shanghai on January 11, 2012. A copy of Mr. Tan's presentation will be archived at [ www.3sbio.com ] under the investor relations section.  

About 3SBio Inc.

3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China.  Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.  With headquarters and MP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 800 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see [ www.3SBio.com ] for more information.

Investor Contacts


Bo Tan
Chief Financial Officer
3SBio Inc.
Tel: + 86 24 2581-1820
[ ir@3SBio.com ]

Tom Folinsbee
Director of Investor Relations
3SBio Inc.
Tel: + 852 8191-6991
[ ir@3SBio.com ]

SOURCE 3SBio Inc.

[ Back to top ]

RELATED LINKS
[ http://www.3sbio.com ]